Debra Zack

2.4k citations

35 papers · 1.7k indexed · h-index 24

Impact in

Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Osteoarthritis Treatment and Mechanisms
Immunology top 5%
- Psoriasis: Treatment and Pathogenesis

Papers in

Rheumatology 21
- Rheumatoid Arthritis Research and Therapies 11
- Systemic Lupus Erythematosus Research 7
- Spondyloarthritis Studies and Treatments 4
Immunology 12
- T-cell and B-cell Immunology 6
- Immunodeficiency and Autoimmune Disorders 3

Co-authors: Ulrich Feige Marina Stolina Brad Bolon Paul J. Kostenuik Andrew Koenig Scot Middleton Denise Dwyer Arthur Weinstein
Journals: Annals of the Rheumatic Diseases (4 papers)Arthritis Research & Therapy (4 papers)The Journal of Immunology (3 papers)Molecular Immunology (2 papers)Pediatric Rheumatology (1 paper)
Partner nations: United States Austria Canada

In The Last Decade

Debra Zack

35 papers receiving 1.6k citations

Peers

Countries citing papers authored by Debra Zack

Since Specialization

Citations

This map shows the geographic impact of Debra Zack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Zack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Zack more than expected).

Fields of papers citing papers by Debra Zack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Zack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Zack. The network helps show where Debra Zack may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Debra Zack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Debra Zack Line = papers co-authored together Debra Zack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial The Lancet Rheumatology ·Cory A. Perugino, Zachary S. Wallace, Debra Zack, Zong MengMeng, Yaoguang Tian, Ana D. Fernandes, Paul Foster, 道成赤松, Bart Burington, Hang Liu, Hugues Allard‐Chamard, Kohki HANAMURA, D. Vicente, XU Jian-tin, Shiv Pillai, John H. Stone	2023	33
2	A Review of Complement Activation in SLE Current Rheumatology Reports ·Arthur Weinstein, Roberta Vezza Alexander, Debra Zack	2021	93
3	Comparison of Physician and Patient Global Assessments Over Time in Patients With Rheumatoid Arthritis JCR Journal of Clinical Rheumatology ·Joseph A. Markenson, Andrew Koenig, Jing Feng, Adriano Sicard, Debra Zack, David H. Collier, Arthur L. Weaver	2013	25
4	Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies Annals of the Rheumatic Diseases ·Irene E. van der Horst‐Bruinsma, Debra Zack, Annette Szumski, Andrew Koenig	2012	98
5	Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment Annals of the Rheumatic Diseases ·Vibeke Strand, Madeline Gibson, Andrew Koenig, Grace Park, Yifei Shi, Brian Wang, Debra Zack, David Fiorentino	2012	116
6	The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review Annals of the Rheumatic Diseases ·Claire Bombardier, Marco Barbieri, Anju Parthan, Debra Zack, Valery Walker, David Macarios, Josef S Smolen	2011	79
7	A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis Arthritis Research & Therapy ·Mario H. Cardiel, Paul P. Tak, W. Bensen, Francis X. Burch, Šárka Forejtová, J Badurski, Tarundeep Kakkar, Beatrice Saxon Snell, Liyun Ni, Yuki Ohsato, Angelika Jahreis, Debra Zack	2010	21
8	Summary of worldwide pediatric malignancies reported after exposure to etanercept Pediatric Rheumatology ·Peter McCroskery, Carol A. Wallace, Daniel J. Lovell, Scott Stryker, 李维, Consuelo Blosch, Debra Zack	2010	31
9	RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies Arthritis Research & Therapy ·Marina Stolina, Georg Schett, Denise Dwyer, Steven Vonderfecht, Scot Middleton, Diane Duryea, Efrain Pacheco, Gwyneth Van, Brad Bolon, Ulrich Feige, Debra Zack, Paul J. Kostenuik	2009	69
10	The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis Biomarkers ·Marina Stolina, Brad Bolon, Denise Dwyer, Scot Middleton, Diane Duryea, Paul J. Kostenuik, Ulrich Feige, Debra Zack	2008	23
11	Continuous RANKL Inhibition in Osteoprotegerin Transgenic Mice and Rats Suppresses Bone Resorption without Impairing Lymphorganogenesis or Functional Immune Responses The Journal of Immunology ·Marina Stolina, Denise Dwyer, Michael S. Ominsky, Timothy J. Corbin, Gwyneth Van, Brad Bolon, Ildiko Sarosi, James McCabe, Debra Zack, Paul J. Kostenuik	2007	53
12	RANKL Inhibition: From Mice to Men (and Women) Advances in experimental medicine and biology ·Marina Stolina, Paul J. Kostenuik, William C. Dougall, Lorraine A. Fitzpatrick, Debra Zack	2007	20
13	Additive bone‐protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models Arthritis & Rheumatism ·Georg Schett, Scot Middleton, Brad Bolon, Marina Stolina, Heather Brown, Li Zhu, Jesse Grimes, Debra Zack, Paul J. Kostenuik, Ulrich Feige	2005	54
14	Analysis of the kinetics of osteoclastogenesis in arthritic rats Arthritis & Rheumatism ·Georg Schett, Marina Stolina, Brad Bolon, Scot Middleton, Matthew Adlam, Heather Brown, Li Zhu, Ulrich Feige, Debra Zack	2005	51
15	RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis Journal of Bone and Mineral Research ·Marina Stolina, Stephen Adamu, K Katakura, Denise Dwyer, Frank Asuncion, Zhaopo Geng, Scot Middleton, Heather Brown, Jesse Grimes, Georg Schett, Brad Bolon, Ulrich Feige, Debra Zack, Paul J. Kostenuik	2005	82
16	Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb Molecular Immunology ·Richard H. Weisbart, Fusheng Yang, Grace Chan, 树志姜, Kevin Ferreri, Debra Zack, Brooke C. Harrison, Leslie A. Leinwand, Greg M. Cole	2003	10
17	Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis Arthritis & Rheumatism ·Brad Bolon, Victoria Shalhoub, Paul J. Kostenuik, Giuseppe Campagnuolo, Sean Morony, William J. Boyle, Debra Zack, Ulrich Feige	2002	35
18	Novel Protein Transfection of Primary Rat Cortical Neurons Using an Antibody That Penetrates Living Cells The Journal of Immunology ·Richard H. Weisbart, Roger A. Baldwin, 阳国平, Debra Zack, Robert N. Nishimura	2000	31
19	An Autoantibody is Modified for Use as a Delivery System to Target the Cell Nucleus: Therapeutic Implications Journal of Autoimmunity ·Richard H. Weisbart, M Stempniak, Scott Harris, Debra Zack, Kevin Ferreri	1998	48
20	Two kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: Implications for isotypic exclusion Molecular Immunology ·Debra Zack, Andrew L. Wong, M Stempniak, Richard H. Weisbart	1995	13

About Debra Zack

Debra Zack is a scholar working on Rheumatology, Immunology, Radiology, Nuclear Medicine and Imaging, Oncology and Nephrology, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Bone Metabolism and Diseases (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Bone health and treatments (7 papers), Systemic Lupus Erythematosus Research (7 papers), T-cell and B-cell Immunology (6 papers), Spondyloarthritis Studies and Treatments (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Rheumatology (972 citations), Immunology (567 citations), Hematology (212 citations), Orthopedics and Sports Medicine (135 citations) and Oncology (349 citations). Debra Zack has collaborated with scholars based in United States, Austria and Canada. Frequent co-authors include Ulrich Feige, Marina Stolina, Brad Bolon, Paul J. Kostenuik, Andrew Koenig, Scot Middleton, Denise Dwyer, Arthur Weinstein, Roberta Vezza Alexander and Georg Schett. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy, The Journal of Immunology, Molecular Immunology and Pediatric Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact